SEARCH:   Advanced

Blood, 1 February 2005, Vol. 105, No. 3, pp. 921-923. Prepublished online as a Blood First Edition Paper on October 5, 2004; DOI 10.1182/blood-2004-06-2404. This Article Full Text (PDF) All Versions of this Article: 2004-06-2404v1 105/3/921    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Weatherall, D. Articles by Hrynkow, S. Search for Related Content PubMed PubMed Citation Articles by Weatherall, D. Articles by Hrynkow, S. Social Bookmarking                   What's this?  Previous Article  |  Next Article  Submitted June 28, 2004 Accepted September 15, 2004 A case for developing North/South partnerships for research in sickle cell disease David Weatherall*, Karen Hofman, Griffin Rodgers, John Ruffin, and Sharon Hrynkow Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom Fogarty International Center, National Institutes of Health, Bethesda, MD, USA Molecular and Clinical Hematology Branch, NIDDK, National Institutes of Health, Bethesda, MD, USA National Center for Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA * Corresponding author; email: david.weatherall{at}ndm.ox.ac.uk. For a better understanding of the pathophysiology and mechanisms of phenotypic diversity of sickle cell disease, and for the improvement of its management globally, there is a strong case for developing sustainable research partnerships between rich and poor countries. CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: I. Roberts and M. de Montalembert Sickle cell disease as a paradigm of immigration hematology: new challenges for hematologists in Europe Haematologica, July 1, 2007; 92(7): 865 - 871. [Full Text] [PDF] G. R. Buchanan and M. J. Kahn Hemolytic anemias ASH Self-Assessment Program, January 1, 2007; 2007(1): 102 - 142. [Full Text] [PDF] J. S. Hankins, R. E. Ware, Z. R. Rogers, L. W. Wynn, P. A. Lane, J. P. Scott, and W. C. Wang Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study Blood, October 1, 2005; 106(7): 2269 - 2275. [Abstract] [Full Text] [PDF] J. S. Hankins, R. E. Ware, Z. R. Rogers, L. W. Wynn, P. A. Lane, J. P. Scott, and W. C. Wang Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study Blood, October 1, 2005; 106(7): 2269 - 2275. [Abstract] [Full Text] [PDF]

	Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020